[{"address1": "3655 Nobel Drive", "address2": "Suite 260", "city": "San Diego", "state": "CA", "zip": "92122", "country": "United States", "phone": "858 926 7655", "website": "https://darebioscience.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Dar\u00e9 Bioscience, Inc., a biopharmaceutical company, develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free, monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia on demand for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of dyspareunia or pain during sexual intercourse; and DARE-HPV, a fixed-dose formulation of lopinavir and ritonavir in a soft gel vaginal insert for the treatment of cervical intraepithelial neoplasia and other human papillomavirus related pathologies. In addition, the company develops DARE-PDM1, a hydrogel formulation of diclofenac for vaginal administration to treat primary dysmenorrhea; DARE-204 and DARE-214, injectable formulations of etonogestrel that provides contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. Further, it develops DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design controlled contraceptive option; DARE-RH1, an approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein; DARE-LBT, a hydrogel formulation for vaginal delivery of live biotherapeutics to support vaginal health; and DARE-GML, a multi-target antimicrobial agent. Dar\u00e9 Bioscience, Inc. is headquartered in San Diego, California.", "fullTimeEmployees": 21, "companyOfficers": [{"maxAge": 1, "name": "Ms. Sabrina Martucci Johnson", "age": 57, "title": "CEO, President, Principal Financial Officer, Secretary & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 641406, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. MarDee J. Haring-Layton", "age": 48, "title": "Chief Accounting Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 409800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Walters", "age": 69, "title": "Vice President of Operations", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Friend Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.93, "open": 2.94, "dayLow": 2.94, "dayHigh": 2.98, "regularMarketPreviousClose": 2.93, "regularMarketOpen": 2.94, "regularMarketDayLow": 2.94, "regularMarketDayHigh": 2.98, "payoutRatio": 0.0, "beta": 1.343, "forwardPE": -2.1911764, "volume": 4293, "regularMarketVolume": 4293, "averageVolume": 22529, "averageVolume10days": 9960, "averageDailyVolume10Day": 9960, "bid": 2.6, "ask": 0.0, "bidSize": 1, "askSize": 0, "marketCap": 26374162, "fiftyTwoWeekLow": 2.67, "fiftyTwoWeekHigh": 7.56, "priceToSalesTrailing12Months": 2695.642, "fiftyDayAverage": 2.96074, "twoHundredDayAverage": 3.287285, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 11978997, "profitMargins": 0.0, "floatShares": 8711877, "sharesOutstanding": 8850390, "sharesShort": 47369, "sharesShortPriorMonth": 87442, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0054, "heldPercentInsiders": 0.01565, "heldPercentInstitutions": 0.0884, "shortRatio": 2.21, "shortPercentOfFloat": 0.0054, "impliedSharesOutstanding": 8850390, "bookValue": -0.691, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -4053599, "trailingEps": -0.48, "forwardEps": -1.36, "lastSplitFactor": "1:12", "lastSplitDate": 1719792000, "enterpriseToRevenue": 1224.346, "enterpriseToEbitda": -0.512, "52WeekChange": -0.18845314, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 2.98, "targetHighPrice": 15.0, "targetLowPrice": 12.0, "targetMeanPrice": 13.33333, "targetMedianPrice": 13.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 15698174, "totalCashPerShare": 1.774, "ebitda": -23409160, "totalDebt": 1303021, "quickRatio": 0.737, "currentRatio": 0.854, "totalRevenue": 9784, "revenuePerShare": 0.001, "returnOnAssets": -0.67570996, "grossProfits": -14295424, "freeCashflow": -7618184, "operatingCashflow": 5394247, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 84.65752, "financialCurrency": "USD", "symbol": "DARE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 1.706483, "regularMarketPrice": 2.98, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1397136600000, "corporateActions": [], "regularMarketTime": 1746216001, "exchange": "NCM", "messageBoardId": "finmb_423979060", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Dare Bioscience, Inc.", "longName": "Dar\u00e9 Bioscience, Inc.", "averageDailyVolume3Month": 22529, "fiftyTwoWeekLowChange": 0.30999994, "fiftyTwoWeekLowChangePercent": 0.11610484, "fiftyTwoWeekRange": "2.67 - 7.56", "fiftyTwoWeekHighChange": -4.58, "fiftyTwoWeekHighChangePercent": -0.6058201, "fiftyTwoWeekChangePercent": -18.845314, "dividendDate": 1500508800, "earningsTimestamp": 1743451260, "earningsTimestampStart": 1746448200, "earningsTimestampEnd": 1746793800, "earningsCallTimestampStart": 1743453000, "earningsCallTimestampEnd": 1743453000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.48, "epsForward": -1.36, "epsCurrentYear": -2.01667, "priceEpsCurrentYear": -1.4776835, "fiftyDayAverageChange": 0.01925993, "fiftyDayAverageChangePercent": 0.0065051066, "twoHundredDayAverageChange": -0.30728507, "twoHundredDayAverageChangePercent": -0.093476854, "priceToBook": -4.3125906, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "regularMarketChange": 0.049999952, "regularMarketDayRange": "2.94 - 2.98", "fullExchangeName": "NasdaqCM", "displayName": "Dar\u00e9 Bioscience", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]